Streetbeat News

Stock Prices

DE

Deep-pocketed investors have adopted a bearish approach towards Deere (NYSE:DE), with significant options trading activity indicating potential market movements. The majority of the options activity is bearish, focusing on a price range between $330.0 and $380.0. Analysts have mixed ratings on Deere, with target prices ranging from $375 to $448.

Portfolio Pulse from Benzinga Insights

July 30, 2024 | 4:32 pm

MMM

Jenny Harrington announced on CNBC that she has sold her position in 3M Company.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 4:29 pm

MRVL

SEMI

SPRX

Marvell Technology (NASDAQ:MRVL) shares are trading lower today after the company introduced its Structera line of Compute Express Link (CXL) devices, aimed at addressing memory performance and scaling challenges in cloud data centers. The new product line is expected to enable optimal resource utilization and lower energy consumption. Marvell also announced that its Teralynx 10 Ethernet switch device is now in volume production. Investors can gain exposure to Marvell through ETFs like Spear Alpha ETF (NASDAQ:SPRX) and Columbia Seligman Semiconductor And Technology ETF (NYSE:SEMI).

Portfolio Pulse from Lekha Gupta

July 30, 2024 | 4:24 pm

EA

Electronic Arts (EA) stock has reached a new 52-week high, trading at $148.40. Investors are anticipating the company's first-quarter earnings report, with expected EPS of 43 cents on revenue of $1.286 billion. EA's significant investment in the upcoming Battlefield game and other projects is also highlighted.

Portfolio Pulse from Henry Khederian

July 30, 2024 | 4:23 pm

TERN

Terns Pharmaceuticals shares are trading lower following the announcement of CFO Mark Vignola's departure.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 4:23 pm

HSII

Heidrick & Struggles shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 net revenue guidance above estimates.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 4:22 pm

TRNS

Transcat shares are trading lower after the company reported worse-than-expected Q1 revenue results.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 4:22 pm

CNSP

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) initially saw its shares rise on Tuesday following the announcement of an exclusive license agreement with Cortice Biosciences for TPI 287, a potential treatment for glioblastoma multiforme (GBM). However, the stock later reversed and is now trading 60% lower at 41 cents. The agreement includes the issuance of 616,698 shares of CNS common stock and potential future milestone payments. CNS plans to consult with the FDA and start a study in 2025.

Portfolio Pulse from Dylan Berman

July 30, 2024 | 4:21 pm

NEO

NeoGenomics shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY24 revenue guidance.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 4:19 pm

CWK

Cushman & Wakefield shares are trading lower after the company reported worse-than-expected Q2 revenue results.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 4:17 pm